ESC Premium Access

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene

Topic: Cardiovascular Risk Assessment

Congress Presentation

About the speaker

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)
3 presentations
0 follower

14 more presentations in this session

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Speaker: Doctor C. Caselli (Pisa, IT)


Effects of evolocumab on LDL-C by race and ethnicity: an analysis of double-blind and open-label extension studies

Speaker: Doctor C. Rodriguez (The Bronx, US)


Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome

Speaker: Professor G. Schwartz (Aurora, US)


Therapeutic effect of nanoliposomal anti-PCSK9 vaccine on hypercholesterolemia and atherosclerosis in C57BL/6 mice.

Speaker: Professor M. Banach (Lodz, PL)


Nanoliposomal anti-PCSK9 vaccine induces long-term and safe protection against atherosclerosis in C57BL/6 mouse.

Speaker: Professor M. Banach (Lodz, PL)


Access the full session

Poster Session 7 - Lipids

Speakers: Doctor H. Tada, Doctor C. Caselli, Doctor C. Rodriguez, Professor G. Schwartz, Professor M. Banach...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by